@FiercePharma: Lovenox copycat sucks market share from Sanofi. Article | Follow @FiercePharma
> ViroPharma, a specialty pharmaceutical company, said U.S. health regulators declined to approve industrial-scale manufacturing of its genetic disorder drug Cinryze, sending its shares down 17 percent. Report
> The Indian pharma market looks poised to grow to $55 billion by 2020, up from $12.6 billion in 2009, according to a new McKinsey & Co. report. News
> China's State Food and Drug Administration and the Shanghai Public Security Bureau are investigating a Beijing pharmaceutical plant allegedly producing a counterfeit version of the drug Avastin. Article
> PhRMA is meeting with Indian officials to review a recent proposal for using compulsory licensing to assure that prices--particularly for cancer and AIDS meds--remain affordable. Story
> Dr Reddy's Laboratories, India's No. 2 drugmaker by sales, reported a 32 percent jump in net profit for the quarter ending September, topping estimates. Item
> Specialty pharmaceutical company Warner Chilcott won the FDA nod for its new low-dose oral contraceptive, Lo Loestrin Fe, sending its shares up 3 percent in pre-market trade. Warner Chilcott release | Report
Biotech News
@FierceBiotech: Aastrom puts hopes in promising CLI therapy. Story | Follow @FierceBiotech
@JohnCFierce: Interesting remark in Economist story on biosimilars: Lots of litigation ahead as Roche/Genentech, Amgen defend turf. Article | Follow @JohnCFierce
> After FDA's ARNA decision, what's next for obesity drugs? News
> Waksal back to deal-making mode, snags Three Rivers for $100M. Report
> Timeline: A look back at Arena's lorcaserin. Article
> FDA throws up a tricky roadblock for Arena's lorcaserin. Item
> Billionaire Allen helps inject $25M into Seattle's Omeros. News
> Genzyme says Sanofi's bid is $4.2B short of reality. Story
Biotech IT News
> Supercomputer to boost drug development, personalized medicine research. Report
> Hamburg seeks something better than randomized trials for drug approvals. Story
> CRO Westat goes digital for clinical signoffs. Article
> Transcept sweats FDA reaction to sleeping pill data. Item
> Simulator provides early view of trial operations. Report
> Savvy users set up to shift among cloud providers. News
And Finally... Pfizer is less than thrilled by what it's seen so far about "Love & Other Drugs," a movie portrayal of a drug-industry sales rep. Report